RecruitingNot ApplicableNCT07044557

MeDex: No Perioperative Dexamethasone in Brain Metastases


Sponsor

University of Louisville

Enrollment

35 participants

Start Date

May 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether brain tumor surgery can be done safely without using steroid medication (dexamethasone) before and after the operation. Doctors routinely give steroids to reduce brain swelling, but steroids have side effects — this trial wants to find out if skipping them is just as safe. **You may be eligible if...** - You are 18 or older - You have a brain tumor on imaging that is suspected or confirmed to be a metastasis (cancer that spread from elsewhere in the body) - You are able to move around on your own more than half the day - Your brain scan shows minimal shifting of brain structures (midline shift ≤10 mm) - Surgery is planned to remove most of the tumor - You have not used steroids recently **You may NOT be eligible if...** - You have additional untreatable brain metastases larger than 2 cm - You have small cell lung cancer - You have been on steroids or need them for another condition - You have severe kidney disease - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERWithholding perioperative Dexamethasone

Patients will not receive perioperative Dex before, during, and up to 3 weeks after surgery.


Locations(1)

University of Louisville Hospital

Louisville, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07044557


Related Trials